Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tumeurs solides
- Lymphomes non hodgkinien
- | Specialty :
- Thérapies Ciblées
Extract
An open-label, phase I, dose-escalation study evaluating the safety and tolerability of GDC-0980 administered once weekly in patients with refractory solid tumors or non-hodgkin's lymphoma.
Scientific Abstract
en cours d'intégration;